• Trial blazers

    Amid the chaos of Brexit, pioneering clinical research continues defiantly, plotting its way through the complexity of disease and providing patients with the currencies of hope, transformation and reinvention.

  • Turning the tide

    Paul Midgley, of Wilmington Healthcare, explores the NHS’ strategy for tackling cardiovascular disease and what these new approaches mean for pharma

  • Driving change

    Gilead Sciences’ Alex Kalomparis says pharma has a role to play in  supporting social change and must not shy away from it

News

View all

Web Exclusives

View all
Thumbnail image for Fostering a ‘golden era’ of medicines innovation

Fostering a ‘golden era’ of medicines innovation

Cooperation and collaboration between the NHS, government and industry will be key to turbocharging the discovery and delivery of a new wave of medical innovations for patients, says Haseeb Ahmad, managing director UK, Ireland and Nordics at Novartis Pharmaceuticals and Country President, Novartis UK.

Thumbnail image for Engaging with patient advocacy groups

Engaging with patient advocacy groups

Harrison Gaiger, marketing manager of the Research Partnership, says working with patient advocacy groups is key to conducting effective rare disease research

Thumbnail image for Turning the tide

Turning the tide

Paul Midgley, of Wilmington Healthcare, explores the NHS’ strategy for tackling cardiovascular disease and what these new approaches mean for pharma

Thumbnail image for Driving change

Driving change

Gilead Sciences’ Alex Kalomparis says pharma has a role to play in  supporting social change and must not shy away from it

Thumbnail image for Opening doors

Opening doors

China’s pharmaceutical market increasingly offers opportunities for UK drugmakers

Thumbnail image for Advancing patient engagement

Advancing patient engagement

Neil McGregor-Paterson explores whether health technology assessment  is leading the field in meaningful patient involvement

Thumbnail image for  Trial blazers

Trial blazers

Amid the chaos of Brexit, pioneering clinical research continues defiantly, plotting its way through the complexity of disease and providing patients with the currencies of hope, transformation and reinvention.

Thumbnail image for Embracing biosimilars

Embracing biosimilars

ICON’s Ioannis Katsoulis, Axel Svedbom, Larushka Mellor and Örjan Åkerborg consider trends and strategies to drive uptake of biosimilars in the UK

Thought Leadership

View all
Thumbnail image for New frontiers

New frontiers

Tom O'Leary considers how the Internet of Medical Things (IoMT) is evolving the patient role in pharma

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download